v3.25.2
Cover Page - USD ($)
12 Months Ended
May 31, 2025
Jun. 30, 2025
Nov. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date May 31, 2025    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --05-31    
Entity Interactive Data Current Yes    
Entity Current Reporting Status Yes    
Entity Registrant Name NEOGEN CORPORATION    
Entity Central Index Key 0000711377    
Trading Symbol NEOG    
Entity Filer Category Large Accelerated Filer    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Small Business false    
Document Annual Report true    
Document Transition Report false    
Entity Public Float     $ 2,716,620,906
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   217,205,186  
Entity File Number 0-17988    
Title of 12(g) Security Common Stock, $0.16 par value per share    
Security Exchange Name NASDAQ    
Entity Incorporation, State or Country Code MI    
Entity Tax Identification Number 38-2367843    
Entity Address, Address Line One 620 Lesher Place    
Entity Address, State or Province MI    
Local Phone Number 372-9200    
Entity Address, City or Town Lansing    
City Area Code 517    
Entity Address, Postal Zip Code 48912    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Auditor Name BDO USA, P.C.    
Auditor Firm ID 243    
Auditor Location Grand Rapids, MI    
Documents Incorporated by Reference [Text Block]

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the registrant’s definitive proxy statement to be prepared pursuant to Regulation 14a and filed in connection with solicitation of proxies for its October 23, 2025 annual meeting of shareholders are incorporated by reference into part III of the Form 10-K.

   
Auditor Opinion [Text Block]

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Neogen Corporation (the “Company”) as of May 31, 2025 and 2024, the related consolidated statements of operations, comprehensive (loss) income, stockholders’ equity, and cash flows for each of the three years in the period ended May 31, 2025, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at May 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended May 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of May 31, 2025, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and our report dated July 30, 2025 expressed an adverse opinion thereon.